Next-Gen Electrolyte Analyzers with Bio-Sensor Cartridge Technology Simplify Clinical Analysis
|
By LabMedica International staff writers Posted on 10 Jul 2023 |

Electrolytes and metabolites offer valuable insights into the body's metabolic processes. Electrolyte analyzers measure ion concentrations in the blood, such as potassium, sodium, bicarbonate, chloride, calcium, glucose, lactate, and magnesium. This analysis helps identify medical conditions like kidney failure, heart failure, uncontrolled diabetes, hemorrhage, chemical poisoning, drug overdose, shock, asthma, and chronic obstructive pulmonary disease (COPD). One of the significant long-term advancements in the electrolyte analyzer market is the creation of technologically enhanced devices and the utilization of sophisticated sensors for monitoring critical parameters like pH level and electrolyte concentration. Now, next-generation electrolyte analyzers with advanced features enable increased accuracy and productivity while shortening the turnaround time for each sample, and reducing human input errors.
The CBS series, a direct ISE analyzer, from B&E Biotechnology Co. Ltd. (Yantai, China) measures whole blood or serum samples directly without the need for dilution. The CBS series (e.g., the CBS-5) measures pH, K, Na, Cl, iCa, and TCO2, and offer simple module replacement. These analyzers come with a 20-hole sample tray and can test 60 samples per hour. The CBS series is popular in numerous countries worldwide, with approximately 10,000 units currently installed. Additionally, the company also offers the KS series of indirect ISE analyzers (e.g., the KS 401) which can automatically dilute samples up to 20 times for testing and can process up to 120 samples per hour. They offer easy electrode module replacement and have a long module lifespan (10,000 samples or two months of operation). With capabilities such as switching between serum mode and urine mode with a single click, direct total calcium testing, and a 60-hole sample tray, the KS series is particularly suitable for medium-sized hospitals. Due to its small sample size, flexibility, and ease of use, the KS series is also making waves in the global market.
Both the CBS and KS series of analyzers utilize multi-sensor modules developed from B&E's extensive technical experience in multi-biosensor technology (MBT). The modules, comprising ceramic plates and specific ion-selective membrane ingredients, exhibit impressive linearity, reproducibility, and long-term stability. Leveraging its MBT applications, B&E has also developed an electrolyte biosensor unit (EBU) that can be adapted to automatic biochemistry analyzers for electrolyte analysis to dramatically reduce running costs.
Related Links:
B&E Biotechnology Co. Ltd.
Latest Clinical Chem. News
- Blood Test Could Predict and Identify Early Relapses in Myeloma Patients
- Compact Raman Imaging System Detects Subtle Tumor Signals
- Noninvasive Blood-Glucose Monitoring to Replace Finger Pricks for Diabetics
- POC Breath Diagnostic System to Detect Pneumonia-Causing Pathogens
- Online Tool Detects Drug Exposure Directly from Patient Samples
- Chemical Imaging Probe Could Track and Treat Prostate Cancer
- Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
Channels
Molecular Diagnostics
view channel
Novel Liquid Biopsy Technology to Advance Cancer Diagnostics
Liquid biopsies are increasingly replacing tissue biopsies in cancer care, offering a faster, minimally invasive way to assess tumor genetics from blood samples. However, current liquid biopsy methods... Read more
POC Oral Fluid Test Diagnoses HIV Infection in 20 Minutes
Timely and accurate HIV diagnosis remains a major challenge in many parts of the world, particularly in resource-constrained settings where laboratory infrastructure and trained personnel are limited.... Read moreHematology
view channel
AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
Alpha thalassemia affects millions of people worldwide and is especially common in regions such as Southeast Asia, where carrier rates can reach extremely high levels. While the condition can have significant... Read more
MRD Tests Could Predict Survival in Leukemia Patients
Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read moreImmunology
view channel
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
New Test Measures How Effectively Antibiotics Kill Bacteria
Antibiotics are typically evaluated by how well they inhibit bacterial growth in laboratory tests, but growth inhibition does not always mean the bacteria are actually killed. Some pathogens can survive... Read more
New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
Antibiotic resistance is rising worldwide, threatening the effectiveness of treatments for major infectious diseases, including tuberculosis (TB). Resistance to key TB drugs, such as bedaquiline, is of... Read morePathology
view channel
Intraoperative Tumor Histology to Improve Cancer Surgeries
Surgical removal of cancer remains the first-line treatment for many tumors, but ensuring that all cancerous tissue is removed while preserving healthy tissue is a major challenge. Surgeons currently rely... Read more
Rapid Stool Test Could Help Pinpoint IBD Diagnosis
Inflammatory bowel disease (IBD) is a chronic condition in which the immune system mistakenly attacks the digestive tract, causing persistent gut inflammation. Diagnosis and disease monitoring often depend... Read more
AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery
Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read moreTechnology
view channelAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
WHX Labs Dubai to Gather Global Experts in Antimicrobial Resistance at Inaugural AMR Leaders’ Summit
World Health Expo (WHX) Labs in Dubai (formerly Medlab Middle East), which will be held at Dubai World Trade Centre from 10-13 February, will address the growing global threat of antimicrobial resistance... Read more







